Evidence map›Paper›PMID 42737387›Full record

ReviewFoods (Basel, Switzerland)2026

Bioactive Peptides from Animal By-Products: Production, Functional Evidence and Food Applications.

Ying-Yan Liang, Bo-Yu Cai, Li Chen, Gui-Can Bi, Jun Xie

Abstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ying-Yan LiangKey Laboratory of Energy Plants Resource and Utilization, Guangdong Engineering Technology Research Center for Agricultural and Forestry Biomass, Ministry of Agriculture and Rural Affairs, College of Future Biomass, South China Agricultural University, Guangzhou 510642, China.
Bo-Yu CaiKey Laboratory of Energy Plants Resource and Utilization, Guangdong Engineering Technology Research Center for Agricultural and Forestry Biomass, Ministry of Agriculture and Rural Affairs, College of Future Biomass, South China Agricultural University, Guangzhou 510642, China.
Li ChenKey Laboratory of Energy Plants Resource and Utilization, Guangdong Engineering Technology Research Center for Agricultural and Forestry Biomass, Ministry of Agriculture and Rural Affairs, College of Future Biomass, South China Agricultural University, Guangzhou 510642, China.
Gui-Can BiKey Laboratory of Energy Plants Resource and Utilization, Guangdong Engineering Technology Research Center for Agricultural and Forestry Biomass, Ministry of Agriculture and Rural Affairs, College of Future Biomass, South China Agricultural University, Guangzhou 510642, China.ORCID 0000-0002-8440-9895
Jun XieKey Laboratory of Energy Plants Resource and Utilization, Guangdong Engineering Technology Research Center for Agricultural and Forestry Biomass, Ministry of Agriculture and Rural Affairs, College of Future Biomass, South China Agricultural University, Guangzhou 510642, China.

Funding

Key Laboratory of Energy Plants Resource and Utilization IBE2024D04
6 · The paper itself

Abstract

Animal-processing by-products contain collagen, myofibrillar proteins, blood proteins, whey proteins, and egg proteins that can be converted into peptide-rich food ingredients. Within a single application-oriented framework, this review integrates source heterogeneity, process control, peptide-profile characterization, tiered functional evidence, food-matrix performance, and regulatory substantiation. Evidence is evaluated for antioxidant, ACE-inhibitory, antimicrobial, DPP-IV-inhibitory, anti-inflammatory, mineral-binding, and taste-modulating functions, while distinguishing chemical assays, cell models, animal studies, human interventions, and tests in real-food matrices. Potential applications include functional foods, dietary supplements, natural preservation, flavor systems, texture modification, active packaging, and oral delivery. Translation remains limited by raw-material heterogeneity, batch variability, sensory defects, processing and gastrointestinal instability, uncertain bioavailability, incomplete safety assessment, and poorly defined regulatory claims. Future work should prioritize source traceability, peptide fingerprints, food-matrix validation, human exposure data, and scalable food-grade production. Compositionally defined peptide mixtures with reproducible functionality may be more practical than single highly purified sequences.

Indexed as

animal by-productsbioactive peptidesfood processingfunctional food ingredientsprotein hydrolysatesstructure-function relationshipsupcycling

Identifiers

PMID42737387
PMCPMC13565139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.